HT
About
HTBT is an enterprise dedicated to the introduction and research and development of diabetes series products and technologies, the construction of industrial clusters of protein oral drug delivery platforms, and the provision of full-course management services for diabetic patients. With flagship goods such oral insulin capsules, recombinant human insulin, insulin analogs, and GLP-1, HTBT aims to establish itself as a credible and reliable biopharmaceutical company and a global biopharmaceutical product R&D and production base (GLP-1 receptor agonists).
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 59 investors are based in Hefei, Anhui, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Hefei, China
Contact Information
linkedin.com/in/••••••••
Find more investors like HTBT
Search Investors